Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y.

Mol Cell Biol. 2003 Dec;23(23):8902-12.

2.

Functions of the MDM2 oncoprotein.

Freedman DA, Wu L, Levine AJ.

Cell Mol Life Sci. 1999 Jan;55(1):96-107. Review.

PMID:
10065155
3.

Control of p53 ubiquitination and nuclear export by MDM2 and ARF.

Zhang Y, Xiong Y.

Cell Growth Differ. 2001 Apr;12(4):175-86. Review.

4.

Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions.

Lindström MS, Deisenroth C, Zhang Y.

Cell Cycle. 2007 Feb 15;6(4):434-7. Epub 2007 Feb 18. Review.

PMID:
17329973
5.

Distinct roles of MDMX in the regulation of p53 response to ribosomal stress.

Gilkes DM, Chen J.

Cell Cycle. 2007 Jan 15;6(2):151-5. Epub 2007 Jan 13. Review.

PMID:
17327702
6.

Signaling to p53: ribosomal proteins find their way.

Zhang Y, Lu H.

Cancer Cell. 2009 Nov 6;16(5):369-77. doi: 10.1016/j.ccr.2009.09.024. Review.

7.

The RP-Mdm2-p53 pathway and tumorigenesis.

Miliani de Marval PL, Zhang Y.

Oncotarget. 2011 Mar;2(3):234-8. Review.

8.

Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.

Bursac S, Brdovcak MC, Donati G, Volarevic S.

Biochim Biophys Acta. 2014 Jun;1842(6):817-30. doi: 10.1016/j.bbadis.2013.08.014. Epub 2013 Oct 26. Review.

9.

[Abnormal p53-HDM2 interaction in hematological malignancy].

Tabe Y, Kojima K.

Nihon Rinsho. 2014 Jun;72(6):1042-6. Review. Japanese.

PMID:
25016801
10.

A new PICTure of nucleolar stress.

Suzuki A, Kogo R, Kawahara K, Sasaki M, Nishio M, Maehama T, Sasaki T, Mimori K, Mori M.

Cancer Sci. 2012 Apr;103(4):632-7. doi: 10.1111/j.1349-7006.2012.02219.x. Epub 2012 Mar 8. Review.

11.

The p53 response to DNA damage.

Meek DW.

DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1049-56. Review.

PMID:
15279792
12.

The regulation of the p53-mediated stress response by MDM2 and MDM4.

Perry ME.

Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a000968. doi: 10.1101/cshperspect.a000968. Review.

13.

Targeting the p53-MDM2 interaction to treat cancer.

Klein C, Vassilev LT.

Br J Cancer. 2004 Oct 18;91(8):1415-9. Review.

14.

Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.

Kim TH, Leslie P, Zhang Y.

Oncotarget. 2014 Feb 28;5(4):860-71. Review.

15.

Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer.

Patel S, Player MR.

Expert Opin Investig Drugs. 2008 Dec;17(12):1865-82. doi: 10.1517/13543780802493366 . Review.

PMID:
19012502
16.

Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response.

Kurki S, Peltonen K, Laiho M.

Cell Cycle. 2004 Aug;3(8):976-9. Epub 2004 Aug 8. Review.

PMID:
15254398
17.

Transcription factors that interact with p53 and Mdm2.

Inoue K, Fry EA, Frazier DP.

Int J Cancer. 2016 Apr 1;138(7):1577-85. doi: 10.1002/ijc.29663. Epub 2015 Jul 14. Review.

18.

C-Abl as a modulator of p53.

Levav-Cohen Y, Goldberg Z, Zuckerman V, Grossman T, Haupt S, Haupt Y.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):737-49. Review.

PMID:
15865930
19.

p53 ubiquitination by Mdm2: a never ending tail?

Coutts AS, Adams CJ, La Thangue NB.

DNA Repair (Amst). 2009 Apr 5;8(4):483-90. doi: 10.1016/j.dnarep.2009.01.008. Epub 2009 Feb 12. Review.

PMID:
19217357
20.

Nucleolar stress in Diamond Blackfan anemia pathophysiology.

Ellis SR.

Biochim Biophys Acta. 2014 Jun;1842(6):765-8. doi: 10.1016/j.bbadis.2013.12.013. Epub 2014 Jan 8. Review.

Supplemental Content

Support Center